Loading...
Immunological effects of adjuvants in subsets of antigen presenting cells of cancer patients undergoing chemotherapy
BACKGROUND: We have previously shown that HCC patients and healthy subjects are equally responsive to a RNAdjuvant(®), a novel TLR-7/8/RIG-I agonist based on noncoding RNA developed by CureVac, by an ex vivo evaluation. However, the immunological effect of adjuvants on immune cells from cancer patie...
Na minha lista:
| Udgivet i: | J Transl Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6977281/ https://ncbi.nlm.nih.gov/pubmed/31973714 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-020-02218-x |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|